April 27th 2024
Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Assessing Health Care Policy Reform at the Federal and State Levels
February 14th 2021In addition to coronavirus disease 2019, several other factors will play a major role in health care policy reform for federal and state-level health officials this year, including the transition to value-based care and containment of high health care costs.
Watch
Biden Reopens ACA Enrollment, Rescinds Global Gag Rule, Will Reexamine Work Requirements
January 28th 2021The Biden administration will reopen the health exchanges created by the Affordable Care Act (ACA); direct HHS and other agencies to reexamine other health policies, including Medicaid work requirements; and reverse the so-called global gag rule while affirming support for reproductive health.
Read More
President Joe Biden reportedly will take executive action to reopen federal marketplaces selling Affordable Care Act (ACA) health plans; Moderna investigating booster shot designed to be more effective against emerging variants of coronavirus disease 2019 (COVID-19); Brazil coronavirus variant is found in Minnesota.
Read More
Analysis Reveals High Cost of Discontinued HMA Treatment for MDS
January 15th 2021New research underscores the substantial economic burden associated with early discontinuation of guideline-recommended hypomethylating agent (HMA) therapy among patients with refractory anemia with excess blasts, a diagnosis that substantially overlaps with higher-risk myelodysplastic syndrome (MDS).
Read More
Addressing Health Insurance Consumer Behavior in 2020, Potential Trends to Watch in 2021
January 15th 2021Based on US health insurance consumer behavior reported in the eHealth Insights: 2020 Retrospective report, notable trends of the past year to watch for in 2021 include the popularity of $0 premium Medicare Advantage plans, the rise of telemedicine, and potential hesitancy against taking a vaccine for coronavirus disease 2019.
Read More
Endocrine Society Calls for Negotiated Insulin Prices in Medicare
January 13th 2021The statement is aimed at drug companies, policymakers, pharmacy benefit managers, employers, and others, and calls to attention soaring insulin costs, which were the subject of several Congressional hearings in 2019.
Read More
How COVID-19 May Drive Changes in Health Care Delivery, Investment in Value-Based Care
January 13th 2021As coronavirus disease 2019 (COVID-19) continues to drive significant change in health care delivery, physician leaders affiliated with the Council for Accountable Physician Practices have worked to increase investment in strategies to address disparities in care exacerbated by the pandemic, such as value-based care and telemedicine.
Watch
Examining the Shift to Value-Based Kidney Care Delivery in 2021
January 12th 2021On this episode of Managed Care Cast, we speak with the new chief financial officer of Strive Health, a value-based kidney care company that works with payers and providers to create an integrated care delivery system for chronic kidney disease and end-stage renal disease (ESRD). We discuss the changes coming to nephrology practices, as well as new ways of looking at the whole patient to halt the slide to irreversible ESRD.
Listen
Dr Milena Murray: Maintaining HIV Viral Load Suppression Can Save Health Care Dollars
December 31st 2020Several economic benefits stem from engaging in care soon after HIV transmission and maintaining viral load suppression, noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor, Midwestern University College of Pharmacy.
Watch
Dr Peter McAllister Explains the Economic Benefits of Migraine Prevention
December 29th 2020Migraine accounts for many billions of dollars in direct and indirect health care costs, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.
Watch
Patients With Atopic Dermatitis Report Broad Array of OOP Expenses Related to Disease
December 26th 2020In addition to significant morbidity and impaired health-related quality of life, patients with atopic dermatitis have a significant out-of-pocket (OOP) financial burden related to their disease.
Read More
Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD
December 15th 2020An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.
Read More